HilleVax, Inc. (HLVX)

USD 1.86

(-2.11%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue - - - - -
Cost of Revenue 2.15 Million 2.25 Million 3000.00 - -
Gross Profit -2.15 Million -2.25 Million -3000.00 - -
Operating Expenses 133.34 Million 62.61 Million 15.77 Million 1.29 Million 633 Thousand
Selling, General and Administrative Expenses 26.66 Million 16.7 Million 5.75 Million 1.29 Million 633 Thousand
Research and Development Expenses 106.68 Million 45.9 Million 10.01 Million - -
Other Expenses - -94.69 Million -20.22 Million -779 Thousand -
Cost and Expenses 133.34 Million 62.61 Million 15.77 Million 1.29 Million 633 Thousand
Operating Income -133.34 Million -65.11 Million -53.42 Million -1.29 Million -633 Thousand
Interest Expense 2.39 Million 3.41 Million 2.84 Million 29 Thousand 9000.00
Income Tax Expense - 97.19 Million -17.38 Million 29 Thousand -633.00
Earnings before Tax -123.56 Million -159.8 Million -102.4 Million -2.1 Million -673 Thousand
Net Income -123.56 Million -257 Million -85.02 Million -2.13 Million -673 Thousand
Earnings Per Share Basic -3.04 -6.83 -2.82 -0.07 -0.02
Earnings Per Share Diluted -3.04 -6.83 -2.82 -0.07 -0.02
Weighted Average Shares Outstanding 40.59 Million 37.65 Million 30.19 Million 30.19 Million 30.19 Million
Weighted Average Shares Outstanding (Diluted) 40.59 Million 37.65 Million 30.19 Million 30.19 Million 30.19 Million
Gross Margin - - - - -
EBIT Margin - - - - -
Profit Margin - - - - -
EBITDA -132.46 Million -65.11 Million -99.56 Million -2.07 Million -31 Thousand
Earnings Before Tax Margin - - - - -

Income Statement Charts